|
1
|
Sun G and Kashyap SR: Cancer risk in type
2 diabetes mellitus: metabolic links and therapeutic
considerations. J Nutr Metab. 2011:7081832011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Noto H, Goto A, Tsujimoto T, Osame K and
Noda M: Latest insights into the risk of cancer in diabetes. J
Diabetes Investig. 4:225–232. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Habib SL and Rojna M: Diabetes and risk of
cancer. ISRN Oncol. 2013:5837862013.PubMed/NCBI
|
|
4
|
Giovannucci E, Harlan DM, Archer MC, et
al: Diabetes and cancer: a consensus report. Diabetes Care.
33:1674–1685. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Garg SK, Maurer H, Reed K and Selagamsetty
R: Diabetes and cancer: two diseases with obesity as a common risk
factor. Diabetes Obes Metab. 16:97–110. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dankner R, Balicer R, Boffetta P, et al:
Diabetes, glucose control, glucose lowering medications, and cancer
risk: a 10-year population-based historical cohort. BMC Cancer.
12:3642012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee IM: Physical activity and cancer
prevention-data from epidemiologic studies. Med Sci Sports Exerc.
35:1823–1827. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Friedenreich CM and Orenstein MR: Physical
activity and cancer prevention: etiologic evidence and biological
mechanisms. J Nutr. 132:3456S–3464S. 2002.PubMed/NCBI
|
|
9
|
Chowdhury TA: Diabetes and cancer. QJM.
103:905–915. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vigneri P, Frasca F, Sciacca L, et al:
Diabetes and cancer. Endocr Relat Cancer. 16:1103–1123. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zendehdel K, Nyren O, Ostenson CG, et al:
Cancer incidence in patients with type 1 diabetes mellitus: a
population-based cohort study in Sweden. J Natl Cancer Inst.
95:1797–1800. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Szablewski L: Diabetes mellitus:
influences on cancer risk. Diabetes Metab Res Rev. 30:543–553.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Handelsman Y, Leroith D, Bloomgarden ZT,
et al: Diabetes and cancer - an AACE/ACE consensus statement.
Endocr Pract. 19:675–693. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li C and Kong D: Cancer risks from
diabetes therapies: evaluating the evidence. Pharmacol Ther.
144:71–81. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Badrick E and Renehan GA: Diabetes and
cancer: 5 years into the recent controversy. Eur J Cancer.
50:2119–2125. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Balbi M, Donadon V, Ghersetti M, et al:
Alcohol and HCV chronic infection are risk cofactors of type 2
diabetes mellitus for hepatocellular carcinoma in Italy. Int J
Environ Res Public Health. 7:1366–1378. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hagberg KW, McGlynn KA, Sahasrabuddhe VV
and Jick S: Anti-diabetic medications and risk of primary liver
cancer in persons with type II diabetes. Br J Cancer.
111:1710–1717. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Burney S, Irfan K, Saif WM and Masud F:
Diabetes and pancreatic cancer. JOP. 15:319–321. 2014.PubMed/NCBI
|
|
19
|
Bosetti C, Rosato V, Li D, et al:
Diabetes, antidiabetic medications and pancreatic risk: an analysis
from the International Pancreatic Cancer Case-Control Consortium.
Ann Oncol. 25:2065–2072. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li D: Diabetes and pancreatic cancer. Mol
Carcinog. 51:64–74. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Stein KB, Snyder CF, Barone BB, et al:
Colorectal cancer outcomes, recurrence, and complications in
persons with and without diabetes mellitus: a systematic review and
meta-analysis. Dig Dis Sci. 55:1839–1851. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bu WJ, Song L, Zhao DY, Guo B and Liu J:
Insulin therapy and the risk of colorectal cancer in patients with
type 2 diabetes: a meta-analysis of observational studies. Br J
Clin Pharmacol. 78:301–309. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yin S, Bai H and Jing D: Insulin therapy
and colorectal cancer risk among type 2 diabetes mellitus patients:
a systemic review and meta-analysis. Diagn Pathol. 9:912014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Peairs KS, Barone BB, Snyder CF, et al:
Diabetes mellitus and breast cancer outcomes: a systematic review
and meta-analysis. J Clin Oncol. 29:40–46. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhu Z, Wang X, Shen Z, et al: Risk of
bladder cancer in patients with diabetes mellitus: an updated
meta-analysis of 36 observational studies. BMC Cancer. 13:3102013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhu Z, Zhang X, Shen Z, et al: Diabetes
mellitus and risk of bladder cancer: a meta-analysis of cohort
studies. PLoS One. 8:e566622013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yoon JM, Son KY, Eom CS, Durrance D and
Park SM: Pre-existing diabetes mellitus increases the risk of
gastric cancer: a meta-analysis. World J Gastroenterol. 19:936–945.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tseng CH: Diabetes but not insulin
increases the risk of lung cancer: a Taiwanese population-based
study. PLoS One. 9:e1015532014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gu Y, Wang C, Zheng Y, et al: Cancer
incidence and mortality in patients with type 2 diabetes treated
with human insulin: a cohort study in Shanghai. PLoS One.
8:e534112013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xu CX, Zhu HH and Zhu YM: Diabetes and
cancer: Associations, mechanisms, and implications for medical
practice. World J Diabetes. 5:372–380. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Orgel E and Mittelman SD: The links
between insulin resistance, diabetes, and cancer. Curr Diab Rep.
13:213–222. 2013. View Article : Google Scholar : PubMed/NCBI
|
